Merck’s Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy?
Merck shares began peeling back in early 2024, mostly on concerns about looming patent expirations for its breadwinning…
Merck Recommends Rejection of Tutanota’s “Mini-Tender” Offer
RAHWAY, N.J., November 22, 2025–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, has…
Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as…